Shares of Kronox Lab Sciences made a decent debut at Dalal Street on Monday as the company was listed at ₹164.95 on NSE, a premium of 21.29% over its issue price of ₹136 apiece. Similarly, the stock kicked off its maiden trading session at a premium of 21.32% to ₹165 on BSE.
Shivani Nyati of Swastika Investmart anticipated a decent listing despite a recent decline in its GMP due to volatile market conditions.Nyati said that investors should be aware of potential risks. "The company's exposure to international markets presents foreign exchange fluctuation risks. Additionally, their current production capacity utilisation is below maximum, and limited product quantities might restrict revenue growth in some areas."Despite these considerations, the analyst said that Kronox Lab Sciences' strong fundamentals, high subscription rate, and still significant GMP suggest a decent listing. However, with the current market volatility, short-term fluctuations are possible, she added. Read more:
